In pediatric osteoporotic patients, diagnosis and treatment is more different than adults.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:AbstractOsteoporosis is a metabolic bone disease characterized by decreased bone mineral density and increased bone fractures in body.
📊
Key Findings & Data:Especially in children with chronic diseases there is an increased risc of osteoporosis.
💡
Conclusion & Impact:In pediatric osteoporotic patients, diagnosis and treatment is more different than adults.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Osteoporoz · Pediatrik hasta · Osteoporosis
Abstract
AbstractOsteoporosis is a metabolic bone disease characterized by decreased bone mineral density and increased bone fractures in body. Especially in children with chronic diseases there is an increased risc of osteoporosis. In pediatric osteoporotic patients, diagnosis and treatment is more different than adults.
Özet
ÖzOsteoporoz kemik mineral yoğunluğunda azalma ve vücutta çeşitli kemiklerdekırık ile seyreden metabolik hastalıktır. Özellikle kronik hastalığı olan çocuklarda osteoporoza riski artmıştır. Çocuk hastalarda tanı ve tedavi izlemi yetişkinlerden farklılık göstermektedir.
DERNEK, U. D. B. (2018). Osteoporosis in Pediatric Patients. Klinik Tıp Pediatri Dergisi, Cilt: 10 - Sayı: 1, 39–43. https://ajindex.com/articles/838389
ep169–ep175. doi: 10.1136/adc.2006.105791 2.Goulding A, Cannan R, Williams SM, et al. BMD in girls withforearm fractures. J Bone Miner Res 1998
143–8. 3.Clark EM, Ness AR, Bishop NJ, et al. Association between bonemass and fractures in children: a prospective cohort study. JBone Miner Res 2006
1489–95. 4.Allgrove J, Shaw NJ (eds): Calcium and Bone Disorders inChildren and Adolescents. 2nd, revised edition. Endocr Dev.Basel, Karger, 2015, vol 28, pp 176–195 (DOI: 10.1159/000381045) 5.Morello R, Bertin TK, Chen Y, et al. CRTAP is required forprolyl 3-hydroxylation and mutations cause recessive osteo-genesis imperfecta. Cell 2006
291–304. 6.Hartikka H, Makitie O, Mannikko M, et al. Heterozygous mu-tations in the LDL receptor related protein 5 (LRP5) gene areassociated with primary osteoporosis in children. J Bone Mi-ner Res 2005
783–9. 7.Gong Y, Slee RB, Fukai N, et al. LDL receptor-related pro-tein 5 (LRP5) affects bone accrual and eye development. Cell2001
513–23. 8.Mäkitie, O. Nat. Rev. Rheumatol. 9, 465–475 (2013)
publis-hed online 16 April 2013
doi:10.1038/nrrheum.2013.45 9.Stevenson RD, Conaway M, Barrington JW, et al. Fracturerate in children with cerebral palsy. Pediatr Rehabil2006
396–403. 10.Binkley T, Johnson J, Vogel L, et al. Bone measurements byperipheral quantitative computed tomography(pQCT) inchildren with cerebral palsy. J Pediatr 2005
791–6. 11.Larson CM, Henderson RC. Bone mineral density and frac-tures in boys with Duchenne muscular dystrophy. J PediatrOrthop 2000
71–4. 12.Sylvester FA, Davis PM, Wyzga N, et al. Are activated T cellsregulators of bone metabolism in children with Crohn disea-se? J Pediatr 2006
461–6. 13.Thearle M, Horlick M, Bilezikian JP, et al. Osteoporosis: anunusual presentation of childhood Crohn’s disease. J Clin En-docrinol Metab 2000
2122–6. 14.Bielinski BK, Darbyshire PJ, Mathers L, et al. Impact of di-sordered puberty on bone density in b thalassaemia major. BrJ Haemat 2003
353–8. 15.Gafni R, Baron J. Overdiagnosis of osteoporosis in childrendue to misinterpretation of dual-energy X-ray absorptiometry(DEXA). J Pediatr 2004
253–7. 16.Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vi-tamin D for corticosteroid-induced osteoporosis. CochraneDatabase Syst Rev 2000
CD000952. 17.Caulton JM, Ward KA, Alsop CW, et al. A randomised con-trolled trial of standing programme on bone mineral densityin non-ambulant ch